Clinical Trial Update: Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of Deferasirox for iron chelation in transfusion-dependent chronic anemia due to myelodysplastic syndromes and beta-thalass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndromes

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myelodysplastic Syndromes, Beta-Thalassemia | Phase 4 | Status: COMPLETED